demonstrated that lower SLC27A5 expression is associated with the progression of ballooning and fibrosis in patients with NAFLD.[20] However, the specific mechanisms underlying SLC27A5 deficiency in liver fibrosis remain unclear. This evidence concerns the gene SLC27A5 and metabolic dysfunction-associated steatotic liver disease.